Financial Perspectives, Inc Cv Rx, Inc. Transaction History

Financial Perspectives, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 09, 2024	SELL	$13.56 - $18.47 $12,095 - $16,475	-892 Reduced 52.5%	807 $12.2 Million
Q4 2021 Jan 09, 2024	BUY	$10.65 - $18.61 $9,499 - $16,600	892 Added 110.53%	1,699 $20.8 Million
Q3 2021 Jan 09, 2024	BUY	$14.65 - $26.07 $11,822 - $21,038	807 New	807 $13.3 Million

13.8M

264K

89.3K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $247M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Perspectives, Inc with notifications on news.